Recall archive / FDA drug enforcement
Kian Pee Wan Capsules, 30-count bottles — FDA record D-0769-2026
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Mar 21, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Kian Pee Wan Capsules, 30-count bottles
- Reason
- Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
- Classification
- Class I
- Recalling firm
- Buy-Herbal
- Quantity
- 71 bottles
- Agency-reported status
- Ongoing
- Source record identifier
- D-0769-2026
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | All lots within expiry. |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Product was sold to individual consumers via ebay third party seller.
No US distribution state could be established from this record. Check the official notice.
Dates in the source
- Report date
- Aug 19, 2026
- Recall initiation date
- Mar 21, 2026
- Center classification date
- Aug 17, 2026
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.